INSULET CORPORATION
PODD · NASDAQ
Insulet Corporation , headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.
Market Data
Price
$238.24
-2.14 (-0.89%)
Market Cap$16.81B
P/E Ratio68.00
EPS$—
52W High$354.88
52W Low$230.05
Beta1.41
Data from Finnhub · Updated Mar 11, 2026